Carlsmed, Inc.
CARL
$9.99
-$0.87-8.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 50.51M | 44.75M | 38.27M | 32.27M | 27.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.51M | 44.75M | 38.27M | 32.27M | 27.17M |
| Cost of Revenue | 12.47M | 11.30M | 9.94M | 8.25M | 7.12M |
| Gross Profit | 38.04M | 33.46M | 28.33M | 24.02M | 20.05M |
| SG&A Expenses | 51.60M | 44.64M | 38.66M | 34.33M | 29.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 81.09M | 70.71M | 62.97M | 56.78M | 51.29M |
| Operating Income | -30.57M | -25.95M | -24.70M | -24.51M | -24.12M |
| Income Before Tax | -29.63M | -25.74M | -25.03M | -24.54M | -24.26M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.63 | -25.74 | -25.03 | -24.54 | -24.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.63M | -25.74M | -25.03M | -24.54M | -24.26M |
| EBIT | -30.57M | -25.95M | -24.70M | -24.51M | -24.12M |
| EBITDA | -30.29M | -25.73M | -24.52M | -24.37M | -23.98M |
| EPS Basic | -3.67 | -4.49 | -6.14 | -6.22 | -6.11 |
| Normalized Basic EPS | -2.21 | -2.72 | -3.66 | -3.71 | -3.73 |
| EPS Diluted | -3.67 | -4.49 | -6.14 | -6.22 | -6.11 |
| Normalized Diluted EPS | -2.21 | -2.72 | -3.66 | -3.71 | -3.73 |
| Average Basic Shares Outstanding | 56.57M | 34.10M | 17.10M | 16.57M | 16.27M |
| Average Diluted Shares Outstanding | 56.57M | 34.10M | 17.10M | 16.57M | 16.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |